Incanthera (AQSE:INC) Purchase Of Investment : £0.00 Mil (TTM As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Incanthera Purchase Of Investment?

Incanthera's purchase of investment for the six months ended in Sep. 2023 was £0.00 Mil. It means Incanthera spent £0.00 Mil on purchasing investments. Incanthera's purchase of investment for the trailing twelve months (TTM) ended in Sep. 2023 was £0.00 Mil.

Compared with last quarter (£0.00 Mil in Mar. 2023 ), Incanthera spent the same money on purchasing investments in Sep. 2023 (£0.00 Mil).

Incanthera Purchase Of Investment Historical Data

The historical data trend for Incanthera's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incanthera Purchase Of Investment Chart

Incanthera Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Purchase Of Investment

Incanthera Semi-Annual Data
	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Purchase Of Investment	Get a 7-Day Free Trial			-	-	-	-	-

Incanthera Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

Incanthera Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Incanthera's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Incanthera (AQSE:INC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Incanthera PLC (AQSE:INC) » Definitions » Purchase Of Investment

Comparable Companies

Traded in Other Exchanges

N/A

Address

76 King Street, Manchester, GBR, M2 4NH

Website

http://www.incanthera.com

Incanthera PLC is a specialist dermatology and oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive. It identifies and develops solutions to current clinical, commercially relevant unmet needs, utilising a new technology. The company's current products are Sol, EP0015, Equin and Duo-C. The company has one segment, namely the development of pharmaceutical products all within the United Kingdom.

Incanthera (AQSE:INC) Headlines

No Headlines